AgriLabs has introduced a newly reformulated, U.S. Department of Agriculture-licensed Colostrx, a colostrum replacer and supplement designed to ensure calves receive valuable immunity and antibodies needed to survive.
The next generation of Colostrx CS and Colostrx CR has a USDA dual claim to aid in the treatment of failure of passive transfer (FPT) of immunity and to aid in the prevention of death associated with Escherichia coli K99 in colostrum-deprived neonatal calves. These two risk factors greatly impact the survival and performance of newborn calves.
"Producers generally get one chance at getting calves off to a strong, healthy start," AgriLabs business unit manager Adam Yankowsky said. "USDA-licensed Colostrx products are specially formulated with true maternal bovine colostrum from U.S. Grade A dairies. They're complete with essential first-day bioactive components, proteins and antibodies, which newborn calves must receive."
Products licensed as Veterinary Biologics by the USDA have production methods assured to be free of infectious agent transmission. This involves regular inspections and approvals of manufacturing processes and facilities.
Colostrx CS and Colostrx CR are tested to be antibiotic-free, synthetic hormone-free and pathogen-free. These products deliver 50 and 100 g of bovine origin IgG and a full natural dose of E. coli K99 antibody with each feeding.